Recombinant human gelsolin | |
---|---|
Trade Name | |
Orphan Indication | The respiratory symptoms of cystic fibrosis |
USA Market Approval | USA |
USA Designation Date | 1994-01-12 00:00:00 |
Sponsor | BioAegis Therapeutics, Inc.;6 East Cove Lane;Morristown, New Jersey, 07960 |